FDA Drugs recall ·

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT)… recall

Recall number
D-0724-2026
Date
(initiated July 13, 2026)
Company / brand
Rising Pharma Holding, Inc.
2 Tower Center Blvd Ste 1401, East Brunswick, NJ, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
74208 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

Why was it recalled?

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.

Distribution

Nationwide U.S.A.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0724-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.